STUDIES IN PROCESS
Validating and progressing positive pre-clinical data into successful Phase I, II and III studies
PharmaJet has formed strategic alliances with leading pharmaceutical, biotechnology, academic institutions and healthcare companies to use our needle-free injection technology to enhance the delivery of injected medicines and vaccines, providing a safe alternative to traditional injection techniques. We have needle-free devices for Intradermal (ID), Subcutaneous (SC), and Intramuscular (IM) delivery in 0.5ml and 0.1mL dose volumes.
We are interested in collaboration opportunities where our technology can enhance the delivery of injectables for our partners in areas such as biologics, vaccines, small molecules, and technologies. Our broad base of applications can deliver:
- Low and high viscosity medicines
- Proteins and peptides
- Specialty drug therapies
- DNA, RNA and nucleic acid vaccines and injectables
PharmaJet currently has active collaborations with a wide variety of partners including, small development companies, big pharmaceutical companies, military/DoD (Department of Defense), Federal agencies, and others.